Takara Bio Inc
TSE:4974
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takara Bio Inc
TSE:4974
|
JP |
|
Casta Diva Group SpA
F:99C
|
IT |
|
G
|
GEA Group AG
XMUN:G1A
|
DE |
|
Swatch Group AG
F:UHRN
|
CH |
|
O
|
Omega Healthcare Investors Inc
LSE:0KBL
|
US |
|
Invisio AB
STO:IVSO
|
SE |
|
Hci Group Inc
LSE:0J22
|
US |
|
F
|
Fresnillo PLC
BMV:FRES
|
MX |
|
E
|
Eni SpA
F:ENI1
|
IT |
|
Mercer International Inc
NASDAQ:MERC
|
CA |
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
CN |
|
Harley-Davidson Inc
NYSE:HOG
|
US |
|
L
|
Life Time Group Holdings Inc
NYSE:LTH
|
US |
|
Sasol Ltd
F:SAOA
|
ZA |
|
P
|
Petroleo Brasileiro SA Petrobras
XMUN:PJXC
|
BR |
|
South32 Ltd
ASX:S32
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Takara Bio Inc's stock price target?
Not Available
Takara Bio Inc does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Takara Bio Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 2 years is 9%.
What is the Gross Profit forecast for Takara Bio Inc?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 2 years is 14%.